The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Concurrent chemoradiotherapy (CRT) with paclitaxel in breast cancer stage II-III.
Eduardo Richardet
No relevant relationships to disclose
Martin Richardet
No relevant relationships to disclose
Romina Brombin
No relevant relationships to disclose
Matias Nicolas Cortes
No relevant relationships to disclose
Matias Molina
No relevant relationships to disclose
Aldo Alejandro Riso
No relevant relationships to disclose
Pablo Companys
No relevant relationships to disclose
Perelli Laura
No relevant relationships to disclose
Patricia Hernandez
No relevant relationships to disclose
Luciana Paola Acosta
No relevant relationships to disclose